The Valley Desk

ArticleActa pharmaceutica Sinica. BPublished

Remodeling macrophage efferocytosis and phenotype via targeted nanoimmunotherapy for atherosclerosis

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names University of Pennsylvania. Affiliation source

Publication record

Type
Article
Venue
Acta pharmaceutica Sinica. B
Published
Subject terms
Atherosclerosis; Macrophages; plaque stability; Efferocytosis; Nanotherapeutics; Inflammation Resolution; M2-like Phenotype; Precise Delivery
PubMed ID
42948745
PubMed Central ID
PMC13712345
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal